Guideline satisfying therapy for chronic heart failure;Leitliniengerechte therapie der chronischen herzinsuffizienz

Internist

Volumn 48, Issue 9, 2007, Pages 929-937

  Hoppe, U C ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cardiac resynchronization; Evidence; Guidelines; Heart failure; Pharmacotherapy

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; EPLERENONE; FOSINOPRIL; FUROSEMIDE; INOTROPIC AGENT; LISINOPRIL; LOSARTAN; METOPROLOL; NEBIVOLOL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE; TRANDOLAPRIL; UNINDEXED DRUG; VALSARTAN; VERAPAMIL;

CARDIAC PATIENT; DIASTOLIC HEART FAILURE; DISEASE SEVERITY; HEART FAILURE; HEART PACING; HUMAN; PATIENT CODING; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SYSTOLIC HEART FAILURE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC PACING, ARTIFICIAL; CARDIOTONIC AGENTS; CHRONIC DISEASE; DIURETICS; GERMANY; HEART FAILURE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 34648831762     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-007-1898-6     Document Type: Review

References (27)

1. Bardy GH, Lee KL, Mark DB et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352: 225-237
2. Bart BA, Boyle A, Bank AJ et al. (2005) Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 46: 2043-2046
3. Bhatia RS, Tu JV, Lee DS et al. (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355: 260-269
4. Bristow MR, Saxon LA, Boehmer J et al. (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350: 2140-2150
5. CIBIS-II Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353: 9-13
6. Cleland JG, Daubert JC, Erdmann E et al. (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352: 1539-1549
7. Cleland JG, Findlay I, Jafri S et al. (2004) The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 148: 157-164
8. Cleland JG, Tendera M, Adamus J et al. (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27: 2338-2345
9. Cohn JN, Tognoni G; for the Valsartan Heart Failure Trial Investigators (2001) A randomized trial of the angiotensin-receptor blocker Valsartan in chronic heart failure. N Engl J Med 345: 1667-1675
10. Costanzo MR, Guglin ME, Saltzberg MT et al. (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49: 675-683
11. Flather MD, Shibata MC, Coats AJ et al. (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26: 215-225
12. Granger CB, McMurray JJ, Yusuf S et al. (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 362: 772-776
13. Hjalmarson A, Goldstein S, Fagerberg B et al. (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 283: 1295-1302
14. Hoppe UC, Böhm M, Dietz R et al. (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Im Auftrag der Deutschen Gesellschaft für Kardiologie. Z Kardiol 94: 488-509
15. Hunt SA, Abraham WT, Chin MH et al. (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112: e154-e235
16. Krum H, Roecker EB, Mohacsi P et al. (2003) Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA 289: 712-718
17. McMurray J, Cohen-Solal A, Dietz R et al. (2001) Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Fail 3: 495-502
18. McMurray JJ, Ostergren J, Swedberg K et al. (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 362: 767-771
19. Moss AJ, Zareba W, Hall WJ et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346: 877-883
20. Pitt B, Remme W, Zannad F et al. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348: 1309-1321
21. Pitt B, Zannad F, Remme WJ et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709-717
22. Rathore SS, Curtis JP, Wang Y et al. (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289: 871-878
23. Remme WJ, Swedberg K (2002) Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4: 11-22
24. SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293-302
25. Swedberg K, Cleland J, Dargie H et al. (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140
26. Willenheimer R, Veldhuisen DJ van, Silke B et al. (2005) Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 112: 2426-2435
27. Yusuf S, Pfeffer MA, Swedberg K et al. (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362: 777-781